SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Hoth Therapeutics, Inc. (Nasdaq – HOTH)

BALA CYNWYD – April 26, 2023 /Newsfile/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Hoth Therapeutics, Inc. (“Hoth” or the “Company”) (Nasdaq – HOTH) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company’s agreement to be acquired by Algorithm Sciences, Inc. (“Algorithm”). Under the terms of the Agreement, on a pro forma basis and based upon the number of shares of Hoth common stock to be issued in the merger, current Hoth shareholders are currently anticipated to own approximately 14% of the combined company and current Algorithm shareholders are currently anticipated to own approximately 86% of the combined company.

The investigation concerns whether the Hoth Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of Hoth shareholders in the combined company.

If you own shares of Hoth stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.